Avalon GloboCare Corp. 10-Q — AI Bull & Bear Analysis

The 10-Q reveals a company at a critical crossroads, attempting to outrun a liquidity crisis through a total business model overhaul. On one hand, the divestiture of real estate and the acquisition of AI capabilities represent a genuine attempt to move into scalable software and diagnostics. On the other hand, the fundamental financial metrics—negative operating cash flow and a persistent working capital deficit—suggest that the company is fighting for survival rather than scaling from a position of strength. Investors are essentially betting on a binary outcome: either the KetoAir and agentic AI platforms can achieve rapid commercial traction to fund operations, or the company will be forced into further dilutive financing or insolvency. The reduction in working capital deficit is a positive sign, but the lack of top-line revenue makes the current valuation a speculative play on future technology adoption rather than a fundamental investment in an operating business.